Kirsten Harting

Kirsten Harting

Director Técnico/Científico/I+D en SYNACT PHARMA AB .
Health Technology
Consumer Services
Commercial Services

Perfil

Kirsten Harting currently works at SynAct Pharma AB, as Chief Medical Officer from 2024 and Tetra Pharm Technologies ApS, as Chief Medical Officer.
Dr. Harting also formerly worked at CytoKi Pharma ApS, as Senior Director-Medical, Alzinova AB, as Chief Medical Officer from 2023 to 2025, and Sandoz Group AG, as Chief Medical Officer.
Dr. Harting received her Masters Business Admin degree from Copenhagen Business School and doctorate degree from the University of Copenhagen.

Cargos activos de Kirsten Harting

EmpresasCargoInicio
SYNACT PHARMA AB Director Técnico/Científico/I+D 15/02/2024
Director Técnico/Científico/I+D -

Antiguos cargos conocidos de Kirsten Harting.

EmpresasCargoFin
ALZINOVA AB Director Técnico/Científico/I+D 28/01/2025
SANDOZ GROUP AG Director Técnico/Científico/I+D -
Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de Kirsten Harting.

Formación de Kirsten Harting.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

2

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology